To gain further insight in the effects of FRC-driven IL-6 signalling in DLBCL tumor cells, the downstream molecular pathways, for example phosphorylation of STAT3, could be investigated in future studies. The gene discussed is STAT3; the disease is diffuse large B-cell lymphoma.